T1	AdverseReaction 55 69;90 100	Vascular risks thrombotic
T2	AdverseReaction 301 314	Liver disease
T3	AdverseReaction 375 394	High blood pressure
T4	AdverseReaction 721 729	Headache
T5	AdverseReaction 829 845	Uterine bleeding
T6	DrugClass 1328 1332	COCs
T7	AdverseReaction 1355 1377	venous thromboembolism
T8	AdverseReaction 1420 1442	venous thromboembolism
T9	Factor 1388 1397	pregnancy
T10	AdverseReaction 1493 1496	VTE
T11	DrugClass 1512 1516	COCs
T12	AdverseReaction 1585 1588	VTE
T13	AdverseReaction 1882 1885	VTE
T14	DrugClass 1924 1927	COC
T15	AdverseReaction 2065 2084	arterial thromboses
T16	DrugClass 2033 2037	COCs
T17	AdverseReaction 2093 2100	strokes
T18	AdverseReaction 2105 2127	myocardial infarctions
T19	AdverseReaction 2207 2229	thromboembolic disease
T20	DrugClass 2237 2256	oral contraceptives
T21	AdverseReaction 2803 2825	cerebrovascular events
T22	AdverseReaction 2827 2837;2854 2861	thrombotic strokes
T23	AdverseReaction 2842 2861	hemorrhagic strokes
T24	AdverseReaction 3638 3651	breast cancer
T25	Negation 3608 3611	not
T26	AdverseReaction 3737 3750	breast cancer
T27	Negation 3777 3790	not confirmed
T28	AdverseReaction 3888 3903	cervical cancer
T29	AdverseReaction 3888 3896;3907 3932	cervical intraepithelial neoplasia
T30	DrugClass 3836 3840	COCs
T31	AdverseReaction 4622 4638	Hepatic adenomas
T32	AdverseReaction 4737 4764	Rupture of hepatic adenomas
T33	AdverseReaction 4775 4780	death
T34	AdverseReaction 4789 4815	intra-abdominal hemorrhage
T35	AdverseReaction 4872 4896	hepatocellular carcinoma
T36	DrugClass 4659 4662	COC
T37	DrugClass 4922 4925	COC
T38	AdverseReaction 4967 4980	liver cancers
T39	DrugClass 4984 4987	COC
T40	AdverseReaction 5066 5077	cholestasis
T41	AdverseReaction 5511 5537	increase in blood pressure
T42	DrugClass 5572 5576	COCs
T43	AdverseReaction 5678 5690	hypertension
T44	AdverseReaction 5843 5862	gallbladder disease
T45	DrugClass 5869 5872	COC
T46	AdverseReaction 6019 6045	decrease glucose tolerance
T47	DrugClass 6010 6014	COCs
T48	AdverseReaction 6326 6338	pancreatitis
T49	DrugClass 6350 6354	COCs
T51	AdverseReaction 6420 6429;6439 6448	headaches recurrent
T50	Severity 6465 6471	severe
T52	AdverseReaction 6420 6429;6450 6460	headaches persistent
T53	AdverseReaction 6574 6582	migraine
T54	DrugClass 6590 6593	COC
T55	AdverseReaction 6627 6648	cerebrovascular event
T56	Factor 6605 6608	may
T57	AdverseReaction 6748 6769	Breakthrough bleeding
T58	AdverseReaction 6774 6782	spotting
T59	AdverseReaction 7408 7418	amenorrhea
T60	AdverseReaction 7422 7436	oligomenorrhea
T61	AdverseReaction 7658 7678	intracyclic bleeding
T62	AdverseReaction 7816 7829	birth defects
T63	Negation 7795 7797	no
T64	AdverseReaction 7923 7941	teratogenic effect
T65	Negation 7909 7912	not
T66	AdverseReaction 7969 7986	cardiac anomalies
T67	AdverseReaction 7991 8013	limb-reduction defects
T68	AdverseReaction 8795 8828	thyroid-binding globulin increase
T69	AdverseReaction 9659 9669	angioedema
T70	Factor 9622 9625	may
T71	AdverseReaction 9671 9679	Chloasma
T72	Factor 9680 9683	may
T75	Factor 1577 1581	risk
T78	DrugClass 2726 2730	COCs
T79	AdverseReaction 3006 3012	stroke
T80	DrugClass 2974 2978	COCs
T81	Factor 4765 4768	may
T82	DrugClass 5039 5057	Oral contraceptive
T83	AdverseReaction 5182 5193	cholestasis
T84	DrugClass 5170 5173	COC
T85	AdverseReaction 6192 6213	adverse lipid changes
T86	DrugClass 6223 6227	COCs
T88	DrugClass 6814 6818	COCs
T89	AdverseReaction 7170 7180	amenorrhea
T90	Factor 7155 7158	may
T91	Factor 7394 7397	may
T92	DrugClass 8841 8845	COCs
T93	AdverseReaction 520 532;543 560	Carbohydrate metabolic effects
T94	AdverseReaction 537 560	lipid metabolic effects
E1	AdverseReaction:T1
E2	AdverseReaction:T2
E3	AdverseReaction:T3
E4	AdverseReaction:T4
E5	AdverseReaction:T5
E6	DrugClass:T6
E7	AdverseReaction:T7 Hypothetical:E6
E8	AdverseReaction:T8 Negated:E9
E9	Factor:T9
E10	AdverseReaction:T10 Hypothetical:E11
E11	DrugClass:T11
E12	AdverseReaction:T12 Hypothetical:E76
E13	AdverseReaction:T13 Hypothetical:E14
E14	DrugClass:T14
E15	AdverseReaction:T15 Hypothetical:E16
E16	DrugClass:T16
E17	AdverseReaction:T17 Hypothetical:E16
E18	AdverseReaction:T18 Hypothetical:E16
E19	AdverseReaction:T19 Hypothetical:E20
E20	DrugClass:T20
E21	AdverseReaction:T21 Hypothetical:E79
E22	AdverseReaction:T22 Hypothetical:E79
E23	AdverseReaction:T23 Hypothetical:E79
E24	AdverseReaction:T24 Negated:E25
E25	Negation:T25
E26	AdverseReaction:T26 Negated:E27
E27	Negation:T27
E28	AdverseReaction:T28 Hypothetical:E30
E29	AdverseReaction:T29 Hypothetical:E30
E30	DrugClass:T30
E31	AdverseReaction:T31 Hypothetical:E36
E32	AdverseReaction:T32
E33	AdverseReaction:T33 Hypothetical:E82
E34	AdverseReaction:T34
E35	AdverseReaction:T35 Hypothetical:E37
E36	DrugClass:T36
E37	DrugClass:T37
E38	AdverseReaction:T38 Hypothetical:E39
E39	DrugClass:T39
E40	AdverseReaction:T40 Hypothetical:E83
E41	AdverseReaction:T41 Hypothetical:E42
E42	DrugClass:T42
E43	AdverseReaction:T43
E44	AdverseReaction:T44 Hypothetical:E45
E45	DrugClass:T45
E46	AdverseReaction:T46 Hypothetical:E47
E47	DrugClass:T47
E48	AdverseReaction:T48 Hypothetical:E49
E49	DrugClass:T49
E51	AdverseReaction:T51 Effect:E50
E50	Severity:T50
E52	AdverseReaction:T51
E53	AdverseReaction:T52
E54	AdverseReaction:T53 Hypothetical:E55
E55	DrugClass:T54
E56	AdverseReaction:T55 Hypothetical:E57
E57	Factor:T56
E58	AdverseReaction:T57 Hypothetical:E89
E59	AdverseReaction:T58 Hypothetical:E89
E60	AdverseReaction:T59 Hypothetical:E92
E61	AdverseReaction:T60 Hypothetical:E92
E62	AdverseReaction:T61
E63	AdverseReaction:T62 Negated:E64
E64	Negation:T63
E65	AdverseReaction:T64 Negated:E66
E66	Negation:T65
E67	AdverseReaction:T66 Negated:E66
E68	AdverseReaction:T67 Negated:E66
E69	AdverseReaction:T68 Hypothetical:E93
E70	AdverseReaction:T69 Hypothetical:E71
E71	Factor:T70
E72	AdverseReaction:T71 Hypothetical:E73
E73	Factor:T72
E76	Factor:T75
E79	DrugClass:T78
E80	AdverseReaction:T79 Hypothetical:E81
E81	DrugClass:T80
E82	Factor:T81
E83	DrugClass:T82
E84	AdverseReaction:T83 Hypothetical:E85
E85	DrugClass:T84
E86	AdverseReaction:T85 Hypothetical:E87
E87	DrugClass:T86
E89	DrugClass:T88
E90	AdverseReaction:T89 Hypothetical:E91
E91	Factor:T90
E92	Factor:T91
E93	DrugClass:T92
E94	AdverseReaction:T93
E95	AdverseReaction:T94
A1	CUI E1 C0040053
A2	UMLS-Preferred-Name E1 Thrombosis
A3	MEDDRA-PT E1 Thrombosis
A4	MEDDRA-PT-ID E1 10043607
A5	CUI E2 C0023895
A6	UMLS-Preferred-Name E2 Liver diseases
A7	MEDDRA-PT E2 Liver disorder
A8	MEDDRA-PT-ID E2 10024670
A9	LLT E2 Hepatic disease
A10	LLT-ID E2 10019650
A11	CUI E3 C0020538
A12	UMLS-Preferred-Name E3 Hypertensive disease
A13	MEDDRA-PT E3 Hypertension
A14	MEDDRA-PT-ID E3 10020772
A15	LLT E3 Blood pressure high
A16	LLT-ID E3 10005747
A17	CUI E4 C0018681
A18	UMLS-Preferred-Name E4 Headache
A19	MEDDRA-PT E4 Headache
A20	MEDDRA-PT-ID E4 10019211
A21	CUI E5 C0042134
A22	UMLS-Preferred-Name E5 Uterine hemorrhage
A23	MEDDRA-PT E5 Uterine haemorrhage
A24	MEDDRA-PT-ID E5 10046788
A25	LLT E5 Uterine bleeding
A26	LLT-ID E5 10046765
A27	CUI E7 C1861172
A28	UMLS-Preferred-Name E7 Venous Thromboembolism
A29	MEDDRA-PT E7 Embolism venous
A30	MEDDRA-PT-ID E7 10014522
A31	LLT E7 Venous thromboembolism
A32	LLT-ID E7 10066899
A33	CUI E8 C1861172
A34	UMLS-Preferred-Name E8 Venous Thromboembolism
A35	MEDDRA-PT E8 Embolism venous
A36	MEDDRA-PT-ID E8 10014522
A37	LLT E8 Venous thromboembolism
A38	LLT-ID E8 10066899
A39	CUI E10 C1861172
A40	UMLS-Preferred-Name E10 Venous Thromboembolism
A41	MEDDRA-PT E10 Embolism venous
A42	MEDDRA-PT-ID E10 10014522
A43	LLT E10 Venous thromboembolism
A44	LLT-ID E10 10066899
A45	CUI E12 C1861172
A46	UMLS-Preferred-Name E12 Venous Thromboembolism
A47	MEDDRA-PT E12 Embolism venous
A48	MEDDRA-PT-ID E12 10014522
A49	LLT E12 Venous thromboembolism
A50	LLT-ID E12 10066899
A51	CUI E13 C1861172
A52	UMLS-Preferred-Name E13 Venous Thromboembolism
A53	MEDDRA-PT E13 Embolism venous
A54	MEDDRA-PT-ID E13 10014522
A55	LLT E13 Venous thromboembolism
A56	LLT-ID E13 10066899
A57	CUI E15 C0151942
A58	UMLS-Preferred-Name E15 Arterial thrombosis
A59	MEDDRA-PT E15 Arterial thrombosis
A60	MEDDRA-PT-ID E15 10003178
A61	CUI E17 C0038454
A62	UMLS-Preferred-Name E17 Cerebrovascular accident
A63	MEDDRA-PT E17 Cerebrovascular accident
A64	MEDDRA-PT-ID E17 10008190
A65	LLT E17 Stroke
A66	LLT-ID E17 10042244
A67	CUI E18 C0027051
A68	UMLS-Preferred-Name E18 Myocardial Infarction
A69	MEDDRA-PT E18 Myocardial infarction
A70	MEDDRA-PT-ID E18 10028596
A71	CUI E19 C0040038
A72	UMLS-Preferred-Name E19 Thromboembolism
A73	MEDDRA-PT E19 Embolism
A74	MEDDRA-PT-ID E19 10061169
A75	LLT E19 Thromboembolism
A76	LLT-ID E19 10043566
A77	CUI E21 C0007820
A78	UMLS-Preferred-Name E21 Cerebrovascular Disorders
A79	MEDDRA-PT E21 Cerebrovascular disorder
A80	MEDDRA-PT-ID E21 10008196
A81	CUI E22 C0242129
A82	UMLS-Preferred-Name E22 Thrombotic stroke
A83	MEDDRA-PT E22 Thrombotic stroke
A84	MEDDRA-PT-ID E22 10043647
A85	CUI E23 C0553692
A86	UMLS-Preferred-Name E23 Brain hemorrhage
A87	MEDDRA-PT E23 Haemorrhagic stroke
A88	MEDDRA-PT-ID E23 10019016
A89	LLT E23 Hemorrhagic stroke
A90	LLT-ID E23 10048863
A91	CUI E24 C0006142
A92	UMLS-Preferred-Name E24 Malignant neoplasm of breast
A93	MEDDRA-PT E24 Breast cancer
A94	MEDDRA-PT-ID E24 10006187
A95	CUI E26 C0006142
A96	UMLS-Preferred-Name E26 Malignant neoplasm of breast
A97	MEDDRA-PT E26 Breast cancer
A98	MEDDRA-PT-ID E26 10006187
A99	CUI E28 C0302592
A100	UMLS-Preferred-Name E28 Cervix carcinoma
A101	MEDDRA-PT E28 Cervix carcinoma
A102	MEDDRA-PT-ID E28 10008342
A103	LLT E28 Cervical cancer
A104	LLT-ID E28 10008229
A105	CUI E29 C0206708
A106	UMLS-Preferred-Name E29 Cervical Intraepithelial Neoplasia
A107	MEDDRA-PT E29 Cervical dysplasia
A108	MEDDRA-PT-ID E29 10008263
A109	LLT E29 Cervical intraepithelial neoplasia
A110	LLT-ID E29 10056576
A111	CUI E31 C0206669
A112	UMLS-Preferred-Name E31 Hepatocellular Adenoma
A113	MEDDRA-PT E31 Hepatic adenoma
A114	MEDDRA-PT-ID E31 10019629
A115	flag E32 duplicate
A116	CUI E32 C0341444
A117	UMLS-Preferred-Name E32 Rupture of liver
A118	MEDDRA-PT E32 Hepatic rupture
A119	MEDDRA-PT-ID E32 10019707
A120	CUI E33 C1306577
A121	UMLS-Preferred-Name E33 Death (finding)
A122	MEDDRA-PT E33 Death
A123	MEDDRA-PT-ID E33 10011906
A124	CUI E34 C0236178
A125	UMLS-Preferred-Name E34 Intraabdominal hemorrhage
A126	MEDDRA-PT E34 Intra-abdominal haemorrhage
A127	MEDDRA-PT-ID E34 10061249
A128	LLT E34 Intra-abdominal hemorrhage
A129	LLT-ID E34 10055291
A130	CUI E35 C2239176
A131	UMLS-Preferred-Name E35 Liver carcinoma
A132	MEDDRA-PT E35 Hepatocellular carcinoma
A133	MEDDRA-PT-ID E35 10073071
A134	CUI E38 C0345904
A135	UMLS-Preferred-Name E38 Malignant neoplasm of liver
A136	MEDDRA-PT E38 Hepatic cancer
A137	MEDDRA-PT-ID E38 10073069
A138	LLT E38 Liver, cancer of
A139	LLT-ID E38 10024720
A140	CUI E40 C0008370
A141	UMLS-Preferred-Name E40 Cholestasis
A142	MEDDRA-PT E40 Cholestasis
A143	MEDDRA-PT-ID E40 10008635
A144	CUI E41 C0497247
A145	UMLS-Preferred-Name E41 Increase in blood pressure
A146	MEDDRA-PT E41 Blood pressure increased
A147	MEDDRA-PT-ID E41 10005750
A148	CUI E43 C0020538
A149	UMLS-Preferred-Name E43 Hypertensive disease
A150	MEDDRA-PT E43 Hypertension
A151	MEDDRA-PT-ID E43 10020772
A152	CUI E44 C0016977
A153	UMLS-Preferred-Name E44 Gall Bladder Diseases
A154	MEDDRA-PT E44 Gallbladder disorder
A155	MEDDRA-PT-ID E44 10017626
A156	LLT E44 Gallbladder disease
A157	LLT-ID E44 10017641
A158	CUI E46 C0151671
A159	UMLS-Preferred-Name E46 Glucose tolerance decreased
A160	MEDDRA-PT E46 Glucose tolerance decreased
A161	MEDDRA-PT-ID E46 10018428
A162	CUI E48 C0030305
A163	UMLS-Preferred-Name E48 Pancreatitis
A164	MEDDRA-PT E48 Pancreatitis
A165	MEDDRA-PT-ID E48 10033645
A166	CUI E51 C0239888
A167	UMLS-Preferred-Name E51 Headache recurrent
A168	MEDDRA-PT E51 Headache
A169	MEDDRA-PT-ID E51 10019211
A170	LLT E51 Headache recurrent
A171	LLT-ID E51 10066618
A172	flag E53 underspecified
A173	CUI E53 C0744648
A174	UMLS-Preferred-Name E53 headache persistent
A175	MEDDRA-PT E53 Headache
A176	MEDDRA-PT-ID E53 10019211
A177	CUI E54 C0149931
A178	UMLS-Preferred-Name E54 Migraine Disorders
A179	MEDDRA-PT E54 Migraine
A180	MEDDRA-PT-ID E54 10027599
A181	CUI E56 C0007820
A182	UMLS-Preferred-Name E56 Cerebrovascular Disorders
A183	MEDDRA-PT E56 Cerebrovascular disorder
A184	MEDDRA-PT-ID E56 10008196
A185	CUI E58 C3495440
A186	UMLS-Preferred-Name E58 Break-through bleeding (finding)
A187	MEDDRA-PT E58 Metrorrhagia
A188	MEDDRA-PT-ID E58 10027514
A189	LLT E58 Bleeding breakthrough
A190	LLT-ID E58 10005105
A191	CUI E59 C0025874
A192	UMLS-Preferred-Name E59 Metrorrhagia
A193	MEDDRA-PT E59 Vaginal haemorrhage
A194	MEDDRA-PT-ID E59 10046910
A195	LLT E59 Spotting vaginal
A196	LLT-ID E59 10048821
A197	CUI E60 C0002453
A198	UMLS-Preferred-Name E60 Amenorrhea
A199	MEDDRA-PT E60 Amenorrhoea
A200	MEDDRA-PT-ID E60 10001928
A201	LLT E60 Amenorrhea
A202	LLT-ID E60 10001927
A203	CUI E61 C0028949
A204	UMLS-Preferred-Name E61 Oligomenorrhea
A205	MEDDRA-PT E61 Oligomenorrhoea
A206	MEDDRA-PT-ID E61 10030295
A207	LLT E61 Oligomenorrhea
A208	LLT-ID E61 10030294
A209	CUI E62 C0025874
A210	UMLS-Preferred-Name E62 Metrorrhagia
A211	MEDDRA-PT E62 Metrorrhagia
A212	MEDDRA-PT-ID E62 10027514
A213	CUI E63 C0000768
A214	UMLS-Preferred-Name E63 Congenital Abnormality
A215	MEDDRA-PT E63 Congenital anomaly
A216	MEDDRA-PT-ID E63 10010356
A217	LLT E63 Birth defects
A218	LLT-ID E63 10048305
A219	CUI E65 C0232910
A220	UMLS-Preferred-Name E65 Teratogenesis
A221	MEDDRA-PT E65 Teratogenicity
A222	MEDDRA-PT-ID E65 10043275
A223	CUI E67 C0018798
A224	UMLS-Preferred-Name E67 Congenital Heart Defects
A225	MEDDRA-PT E67 Heart disease congenital
A226	MEDDRA-PT-ID E67 10019273
A227	LLT E67 Anomaly cardiac
A228	LLT-ID E67 10002616
A229	CUI E68 C0265547
A230	UMLS-Preferred-Name E68 Longitudinal deficiency of limb
A231	MEDDRA-PT E68 Limb reduction defect
A232	MEDDRA-PT-ID E68 10024503
A233	CUI E69 C0241400
A234	UMLS-Preferred-Name E69 Thyroxin binding globulin increased
A235	MEDDRA-PT E69 Thyroxin binding globulin increased
A236	MEDDRA-PT-ID E69 10051420
A237	CUI E70 C0002994
A238	UMLS-Preferred-Name E70 Angioedema
A239	MEDDRA-PT E70 Angioedema
A240	MEDDRA-PT-ID E70 10002424
A241	CUI E72 C0025218
A242	UMLS-Preferred-Name E72 Chloasma
A243	MEDDRA-PT E72 Chloasma
A244	MEDDRA-PT-ID E72 10008570
A245	CUI E80 C0038454
A246	UMLS-Preferred-Name E80 Cerebrovascular accident
A247	MEDDRA-PT E80 Cerebrovascular accident
A248	MEDDRA-PT-ID E80 10008190
A249	LLT E80 Stroke
A250	LLT-ID E80 10042244
A251	CUI E84 C0008370
A252	UMLS-Preferred-Name E84 Cholestasis
A253	MEDDRA-PT E84 Cholestasis
A254	MEDDRA-PT-ID E84 10008635
A255	CUI E86 C0549634
A256	UMLS-Preferred-Name E86 Lipids abnormal
A257	MEDDRA-PT E86 Lipids abnormal
A258	MEDDRA-PT-ID E86 10024588
A259	CUI E90 C0002453
A260	UMLS-Preferred-Name E90 Amenorrhea
A261	MEDDRA-PT E90 Amenorrhoea
A262	MEDDRA-PT-ID E90 10001928
A263	LLT E90 Amenorrhea
A264	LLT-ID E90 10001927
A265	CUI E94 C0149670
A266	UMLS-Preferred-Name E94 Disorder of carbohydrate metabolism
A267	MEDDRA-PT E94 Carbohydrate metabolism disorder
A268	MEDDRA-PT-ID E94 10061023
A269	CUI E95 C0154251
A270	UMLS-Preferred-Name E95 Lipid Metabolism Disorders
A271	MEDDRA-PT E95 Lipids abnormal
A272	MEDDRA-PT-ID E95 10024588
